Adma Biologics (ADMA) EBITDA Margin (2011 - 2026)
Adma Biologics (ADMA) reported EBITDA Margin of 43.59% for Q2 2026, up 6.82 percentage points from 36.77% a year earlier but down 8.91 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) EBITDA Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Adma Biologics' EBITDA Margin came in at 45.32%, up 10.83 percentage points year-over-year; for FY2025, it was 39.11%, up 4.64 percentage points from FY2024.
- EBITDA Margin has increased for five consecutive years, with a five-year change of +183.53 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 34.48% in FY2024 (+22.87 pp), 11.60% in FY2023 (+32.54 pp), -20.93% in FY2022 (+44.40 pp) and -65.33% in FY2021 (+79.09 pp).
- Five-year quarterly EBITDA Margin spans a low of -62.93% in Q3 2021 and a high of 52.50% in Q1 2026.
- Year over year, EBITDA Margin has now increased in each of the last four quarters, with an average year-over-year change of +9.54 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q4 2021 (a gain of 70.31 percentage points); the low point was Q2 2025 (a drop of 1.71 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 52.50% (Q1 2026), 46.56% (Q4 2025) and 39.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn | 43.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.59% |
| Mar 31, 2026 | 52.50% |
| Dec 31, 2025 | 46.56% |
| Sep 30, 2025 | 39.51% |
| Jun 30, 2025 | 36.77% |
| Mar 31, 2025 | 32.10% |
| Dec 31, 2024 | 34.26% |
| Sep 30, 2024 | 34.69% |
| Jun 30, 2024 | 38.48% |
| Mar 31, 2024 | 29.23% |
| Dec 31, 2023 | 22.11% |
| Sep 30, 2023 | 16.02% |
| Jun 30, 2023 | 2.70% |
| Mar 31, 2023 | 2.14% |
| Dec 31, 2022 | -8.25% |
| Sep 30, 2022 | -18.14% |
| Jun 30, 2022 | -21.97% |
| Mar 31, 2022 | -45.44% |
| Dec 31, 2021 | -44.24% |
| Sep 30, 2021 | -62.93% |
API Access
Adma Biologics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();